METH-2 silencing and promoter hypermethylation in NSCLC

Keyphrases

• Promoter Methylation 100%
• Non-small Cell Lung Cancer (NSCLC) 100%
• Immunohistochemical Analysis 16%
• DNA Methylation Analysis 16%
• Allelic Imbalance 16%
• Squamous Cell Carcinoma (SqCC) 16%
• Tumor Samples 16%
• Single nucleotide Polymorphism 16%
• Promoter Region 16%
• MRNA Expression 16%
• Proximal Promoter 16%
• Non-tumor Tissue 16%
• Epigenetic Mechanisms 16%
• Lung Cancer Cell Lines 16%
• Hypermethylation 16%
• Adenocarcinoma 16%
• CDNA Microarray Analysis 16%
• Antiangiogenic Factors 16%
• Homozygous Deletion 16%
• ADAMTS 16%
• Multiplex RT-PCR 16%
• Dual-channel 16%

Biochemistry, Genetics and Molecular Biology

• Promoter Region 100%
• Messenger RNA 33%
• Allelic Imbalance 33%
• Reverse Transcription Polymerase Chain Reaction 33%
• Single-Nucleotide Polymorphism 33%
• DNA Methylation 33%
• down Regulation 33%
• Cancer Cell 33%
• Epigenetic Mechanism 33%
• ADAMTS 33%
• cDNA Microarray 33%

Immunology and Microbiology

• Promoter Region 100%
• Squamous Cell 33%
• Allelic Imbalance 33%
• Reverse Transcription Polymerase Chain Reaction 33%
• Single Nucleotide Polymorphism 33%
• down Regulation 33%
• Lung Cancer Cell Line 33%
• Epigenetic Mechanism 33%
• DNA Methylation 33%